Cases 1 - 10 of 85
Pfizer Inc. et al v. Zydus Lifesciences Ltd. et al
as 1:2024cv00316
Plaintiff:
Pfizer Inc., Global Blood Therapeutics, Inc. and PF PRISM IMB B.V.
Defendant:
Zydus Lifesciences Ltd., Zydus Worldwide DMCC and Zydus Pharmaceuticals (USA) Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Allergan USA, Inc., et al. v. MSN Laboratories Private Limited, et al.
as 1:2019cv01727
Counter Defendant:
Allergan USA, Inc., Allergan Holdings Unlimited Company and Eden Biodesign, LLC
Counter Claimant:
MSN Laboratories Private Limited, Alkem Laboratories Limited, Hetero USA Inc. and others
Plaintiff:
Eden Biodesign, LLC.
Defendant:
Sun Pharmaceutical Industries Limited, Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Azurity Pharmaceuticals, Inc. et al v. Zydus Worldwide DMCC et al
as 1:2023cv00833
Plaintiff:
Azurity Pharmaceuticals, Inc., Arbor Pharmaceuticals, LLC and Takeda Pharmaceutical Company Limited
Defendant:
Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Zydus Lifesciences Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Astellas Pharma Inc. et al v. Lupin Ltd. et al
as 1:2023cv00819
Plaintiff:
Astellas Pharma Inc., Astellas Ireland Co., Ltd. and Astellas Pharma Global Development, Inc.
Defendant:
Lupin Ltd., Lupin Pharmaceuticals, Inc., Sandoz Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Par Pharmaceutical, Inc. et al v. Zydus Pharmaceuticals (USA) Inc. et al
as 1:2023cv00866
Plaintiff:
Par Pharmaceutical, Inc. and Epic Par Innovation Company, LLC
Defendant:
Zydus Pharmaceuticals (USA) Inc. and Zydus Lifesciences Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Astellas Pharma Inc. et al v. Sandoz Inc. et al
as 1:2020cv01589
Defendant:
Sawai Pharmaceutical Co., Ltd., Cadila Healthcare Ltd. doing business as Zydus Cadila, Apotex Inc. and others
Plaintiff:
Astellas Pharma Inc., Astellas Ireland Co., Ltd. and Astellas Pharma Global Development, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Biogen Inc. et al v. Zydus Worldwide DMCC et al
as 1:2023cv00732
Plaintiff:
Biogen Inc., Biogen Swiss Manufacturing GmbH and Alkermes Pharma Ireland Limited
Defendant:
Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Zydus Lifesciences Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In Re: Ozempic (Semaglutide) Patent Litigation
as 1:2022md03038
Not Classified By Court:
Zydus Lifesciences Limited, Ozempic (Semaglutide) Patent Litigation, Novo Nordisk Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Neurocrine Biosciences, Inc. v. Zydus Pharmaceuticals (USA) Inc. et al
as 1:2023cv00266
Defendant:
Zydus Lifesciences Limited formerly known as Cadila Healthcare Limited doing business as Zydus Cadila, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC and others
Plaintiff:
Neurocrine Biosciences, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Exelixis, Inc. v. Zydus Pharmaceuticals USA Inc.
as 1:2023mc00132
Petitioner:
Exelixis, Inc.
Respondent:
Zydus Pharmaceuticals USA Inc.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
